In this study, we investigated the intertumoral heterogeneity of dMMR/MSI colorectal cancers, and our findings indicate that GALNT7 expression serves as a robust prognostic biomarker in this subgroup. This evidence concerns the gene GALNT7 and colorectal cancer.